Search all trials

Find therapies in clinical trials near you

Search by disease and location to discover available clinical trials matching your criteria. Updated every day from authoritative EU registries.

recruiting: 3 962
countries: 28
conditions: 2 101

3 962 trials recruiting28 European countries2 101 conditions coveredUpdated today

Quick filters

Craniocerebral injury

Recruiting

Investigational

Phase 2a Study of Safety, Tolerability and Efficacy of Intranasal Cenegermin in Adults with Moderate to Severe Subacute Traumatic Brain Injury

Investigational

Italy

Participants:18–64 years · 65+ years
Substances:Cenegermin

Contact Research Centre

Atrial fibrillation

Recruiting

Investigational

Study on the Effectiveness of Abelacimab for High-Risk Atrial Fibrillation Patients Unsuitable for Oral Anticoagulation

Investigational

Italy

Participants:65+ years
Substances:Abelacimab

Contact Research Centre

End stage renal disease+1

Recruiting

Registered drug

Study of Patiromer to Allow Less Dietary Potassium Restrictions in Patients on Chronic Dialysis with Controlled Blood Potassium Levels

Registered drug

Italy

Participants:18–64 years · 65+ years
Substances:Patiromer

Contact Research Centre

Non-small cell lung cancer

Recruiting

Registered drugNo placebo

Study on Tedopi and Nivolumab for Patients with Advanced Non-Small Cell Lung Cancer After Initial Treatment

Registered drugNo placebo

Italy

Participants:18–64 years · 65+ years
Substances:Mps-102

Contact Research Centre

Ovarian cancer

Recruiting

Registered drugNo placebo

Study on Olaparib for Maintenance Therapy in Patients with Newly Diagnosed Advanced Ovarian, Fallopian Tube, and Peritoneal Cancer

Registered drugNo placebo

Italy

Participants:18–64 years · 65+ years
Substances:Olaparib

Contact Research Centre

Metastatic renal cell carcinoma

Recruiting

Registered drugNo placebo

Study of Axitinib and Nivolumab for Patients with Metastatic Renal Cell Carcinoma Not Responding Completely to Initial Treatment

Registered drugNo placebo

Italy

Participants:18–64 years · 65+ years
Substances:Axitinib

Contact Research Centre

Atrial fibrillation

Not yet recruiting

Investigational

Stroke and Systemic Embolism Prevention with REGN7508 and REGN9933 in Adults with Atrial Fibrillation Unsuitable for Oral Anticoagulation (Phase 3)

Investigational

Italy

Participants:18–64 years · 65+ years
Substances:Regn7508

Contact Research Centre

Squamous cell carcinoma of lung

Not yet recruiting

Registered drugNo placebo

Study of Cemiplimab, Platinum and Gemcitabine in Treatment‑Naïve Patients with Advanced Squamous Non‑Small Cell Lung Cancer

Registered drugNo placebo

Italy

Participants:18–64 years
Substances:Cemiplimab

Contact Research Centre

Non-small cell lung cancer

Not yet recruiting

Registered drugNo placebo

Study of Cabozantinib for Patients with Non-Small Cell Lung Cancer and MET Deregulation

Registered drugNo placebo

Italy

Participants:18–64 years · 65+ years
Substances:Cabozantinib

Contact Research Centre

Non-small cell lung cancer

Not yet recruiting

Registered drugNo placebo

Study on the Best Treatment Sequence for Advanced Non-Small Cell Lung Cancer with EGFR Mutations Using Dacomitinib and Osimertinib

Registered drugNo placebo

Italy

Participants:18–64 years · 65+ years
Substances:Dacomitinib

Contact Research Centre

Breast cancer

Not recruiting

Registered drugNo placebo

Study on Chemotherapy and Aromatase Inhibitors (Exemestane, Letrozole, Anastrozole) for Post-Menopausal Patients with Early Breast Cancer

Registered drugNo placebo

Italy

Participants:18–64 years · 65+ years
Substances:Anastrozole

Contact Research Centre

Find therapies in clinical trials near you

11 trials match your criteria

Craniocerebral injury

Phase 2a Study of Safety, Tolerability and Efficacy of Intranasal Cenegermin in Adults with Moderate to Severe Subacute Traumatic Brain Injury

Atrial fibrillation

Study on the Effectiveness of Abelacimab for High-Risk Atrial Fibrillation Patients Unsuitable for Oral Anticoagulation

End stage renal disease+1

Study of Patiromer to Allow Less Dietary Potassium Restrictions in Patients on Chronic Dialysis with Controlled Blood Potassium Levels

Non-small cell lung cancer

Study on Tedopi and Nivolumab for Patients with Advanced Non-Small Cell Lung Cancer After Initial Treatment

Ovarian cancer

Study on Olaparib for Maintenance Therapy in Patients with Newly Diagnosed Advanced Ovarian, Fallopian Tube, and Peritoneal Cancer

Metastatic renal cell carcinoma

Study of Axitinib and Nivolumab for Patients with Metastatic Renal Cell Carcinoma Not Responding Completely to Initial Treatment

Atrial fibrillation

Stroke and Systemic Embolism Prevention with REGN7508 and REGN9933 in Adults with Atrial Fibrillation Unsuitable for Oral Anticoagulation (Phase 3)

Squamous cell carcinoma of lung

Study of Cemiplimab, Platinum and Gemcitabine in Treatment‑Naïve Patients with Advanced Squamous Non‑Small Cell Lung Cancer

Non-small cell lung cancer

Study of Cabozantinib for Patients with Non-Small Cell Lung Cancer and MET Deregulation

Non-small cell lung cancer

Study on the Best Treatment Sequence for Advanced Non-Small Cell Lung Cancer with EGFR Mutations Using Dacomitinib and Osimertinib

Breast cancer

Study on Chemotherapy and Aromatase Inhibitors (Exemestane, Letrozole, Anastrozole) for Post-Menopausal Patients with Early Breast Cancer

Explore other searches

Vaccine trials

Paediatric trials · ages 0–17

Healthy volunteers

Helpful resources

How applying through us works

What happens after you apply

Guides for patients and volunteers

Search filters

Prefer not to search? Our Concierge searches the trials for you.